Literature DB >> 3004934

Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion.

D Jenne, K K Stanley.   

Abstract

cDNA clones coding for human S-protein have been isolated using monoclonal antibodies to screen a cDNA library in pEX. These clones are shown to be authentic S-protein clones on the basis of sequence, composition and immunological criteria. The complete open reading frame sequence for S-protein has been determined and shows it to be a single polypeptide chain of 459 amino acids preceded by a cleaved leader peptide of 19 residues. No evidence was found for polymorphism of S-protein suggesting that different molecular weight forms arise by proteolytic degradation. Of the first 44 amino-terminal residues 42 are identical with the so-called somatomedin B peptide suggesting that S-protein is the somatomedin B precursor. Striking homology is found in the rest of the sequence with the serum spreading factor, vitronectin, which has also been shown to contain somatomedin B sequences at its amino terminus. We conclude that S-protein and vitronectin are identical and discuss the relevance of this finding to the coagulation and complement pathways.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3004934      PMCID: PMC554635          DOI: 10.1002/j.1460-2075.1985.tb04058.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  39 in total

Review 1.  Cell adhesion and the molecular processes of morphogenesis.

Authors:  G M Edelman
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

2.  Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.

Authors:  E R Podack; K T Preissner; H J Müller-Eberhard
Journal:  Acta Pathol Microbiol Immunol Scand Suppl       Date:  1984

3.  Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group.

Authors:  B Dahlbäck; E R Podack
Journal:  Biochemistry       Date:  1985-04-23       Impact factor: 3.162

4.  Localization of the terminal C5b-9 complement complex in the human aortic atherosclerotic wall.

Authors:  F Niculescu; H Rus; A Cristea; R Vlaicu
Journal:  Immunol Lett       Date:  1985       Impact factor: 3.685

5.  Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus.

Authors:  R J Falk; A P Dalmasso; Y Kim; S Lam; A Michael
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245

6.  Monoclonal antibodies to human plasma protein X alias complement S-protein.

Authors:  D Jenne; F Hugo; S Bhakdi
Journal:  Biosci Rep       Date:  1985-04       Impact factor: 3.840

7.  Possible involvement of terminal complement complex in active Heymann nephritis.

Authors:  E de Heer; M R Daha; S Bhakdi; H Bazin; L A van Es
Journal:  Kidney Int       Date:  1985-02       Impact factor: 10.612

8.  Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins.

Authors:  K K Stanley; J P Luzio
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

9.  The sequence and topology of human complement component C9.

Authors:  K K Stanley; H P Kocher; J P Luzio; P Jackson; J Tschopp
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

10.  Detachment of cells from culture substrate by soluble fibronectin peptides.

Authors:  E G Hayman; M D Pierschbacher; E Ruoslahti
Journal:  J Cell Biol       Date:  1985-06       Impact factor: 10.539

View more
  38 in total

1.  Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A.

Authors:  D Chain; B Korc-Grodzicki; T Kreizman; S Shaltiel
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

2.  Blood dendritic cells carry terminal complement complexes on their cell surface as detected by newly developed neoepitope-specific monoclonal antibodies.

Authors:  R Würzner; H Xu; A Franzke; M Schulze; J H Peters; O Götze
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

3.  Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials.

Authors:  T E Mollnes; V Videm; J Riesenfeld; P Garred; J L Svennevig; E Fosse; K Hogasen; M Harboe
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

4.  Quantitation of vitronectin in serum: evaluation of its usefulness in routine clinical practice.

Authors:  N A Boyd; A R Bradwell; R A Thompson
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

Review 5.  Functions and relevance of the terminal complement sequence.

Authors:  S Bhakdi; F Hugo; J Tranum-Jensen
Journal:  Blut       Date:  1990-06

6.  Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.

Authors:  H J Weiss; J Hawiger; Z M Ruggeri; V T Turitto; P Thiagarajan; T Hoffmann
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

7.  Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli.

Authors:  G S Chhatwal; K T Preissner; G Müller-Berghaus; H Blobel
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

8.  Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.

Authors:  L Milis; C A Morris; M C Sheehan; J A Charlesworth; B A Pussell
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

9.  Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor.

Authors:  M Okada; K Yoshioka; T Takemura; N Akano; N Aya; K Murakami; S Maki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

10.  Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.

Authors:  F Niculescu; F Hugo; H G Rus; R Vlaicu; S Bhakdi
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.